Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 3,500 peer-reviewed publications. The CPRD bibliography listed below is updated on a monthly basis (last updated 4 April 2024).

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download: CPRD bibliography PDF March 2024 (PDF, 4.2MB, 313 pages) 

Download: CPRD bibliography .BIB April 2024 (BIB, 1.3MB, 1 page)

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

Page last reviewed

05-04-2024

Year	Title
2015	What are the effects of varenicline compared with nicotine replacement therapy on long-term smoking cessation and clinically important outcomes? Protocol for a prospective cohort study 10.1136/bmjopen-2015-009665 Authors: N. Davies, G. Taylor, A. Taylor, K. Thomas, F. Windmeijer, R. Martin, M. Munafo
2020	What are the implications of using individual and combined sources of routinely collected data to identify and characterise incident site-specific cancers? a concordance and validation study using linked English electronic health records data 10.1136/bmjopen-2020-037719 Authors: H. Strongman, R. Williams, K. Bhaskaran
2009	What happens to new-onset headache in children that present to primary care? A case-cohort study using electronic primary care records 10.1111/j.1468-2982.2009.01872.x Authors: D. Kernick, S. Stapley, J. Campbell, W. Hamilton
2004	What has happened to antimicrobial usage in primary care in the United Kingdom since the SMAC report? - description of trends in antimicrobial usage using the General Practice Research Database 10.1093/pubmed/fdh179 Authors: G. Smith, S. Smith, H. Heatlie, J. Bashford, J. Hawker, D. Ashcroft, D. Millson, N. Verlander, R. Warren
2008	What is the harm-benefit ratio of Cox-2 inhibitors? 10.1093/ije/dym296 Authors: T. van Staa, L. Smeeth, I. Persson, J. Parkinson, H. Leufkens
2018	What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England? A trend analysis in the Clinical Practice Research Datalink 10.1186/s13195-018-0379-6 Authors: V. Walker, N. Davies, P. Kehoe, R. Martin
2019	What is the incidence of late detection of developmental dysplasia of the hip in England? 10.1302/0301-620x.101b3.bjj-2018-1331.r1 Authors: C. Broadhurst, A. Rhodes, P. Harper, D. Perry, N. Clarke, A. Aarvold
2021	What is the incidence of methotrexate or leflunomide discontinuation related to cytopenia, liver enzyme elevation or kidney function decline? 10.1093/rheumatology/keab254 Authors: G. Nakafero, M. Grainge, T. Card, C. Mallen, W. Zhang, M. Doherty, M. Taal, G. Aithal, A. Abhishek
2020	What is the optimal blood pressure level for patients with atrial fibrillation treated with direct oral anticoagulants? 10.1097/hjh.0000000000002487 Authors: J. Minhas, B. Coles, A. Mistri, D. Eveson, S. Hussain, J. Potter, K. Khunti, T. Robinson
2015	What is the risk of having a total hip or knee replacement for patients with lupus? 10.1177/0961203314547894 Authors: S. Mukherjee, D. Culliford, N. Arden, C. Edwards
2020	What Next After Metformin in Type 2 Diabetes? Selecting the Right Drug for the Right Patient 10.1007/s13300-020-00834-w Authors: W. Strain, C. Tsang, M. Hurst, P. McEwan, M. Unadkat, S. Meadowcroft, R. Shardlow, M. Evans
2012	What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes 10.1210/jc.2012-3034 Authors: C. Morgan, C. Poole, M. Evans, A. Barnett, S. Jenkins-Jones, C. Currie
2019	What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND study 10.1186/s12916-019-1307-8 Authors: A. McGovern, J. Dennis, B. Shields, A. Hattersley, E. Pearson, A. Jones
2019	What were the impacts of the Committee on Safety of Medicines warning and publication of the NICE guidelines on trends in child and adolescent antidepressant prescribing in primary care? A population based study 10.1136/bmjopen-2018-028201 Authors: P. Tiffin, J. Mediavilla, H. Close, A. Kasim, P. Welsh, L. Paton, J. Mason
2016	When are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data 10.1182/blood-2015-01-625582 Authors: A. Walker, J. West, T. Card, C. Crooks, C. Kirwan, M. Grainge
2017	Where are the opportunities for an earlier diagnosis of primary intracranial tumours in children and young adults? 10.1016/j.ejpn.2016.10.010 Authors: T. Chu, A. Shah, D. Walker, M. Coleman
2016	Which Patients with Giant Cell Arteritis Will Develop Cardiovascular or Cerebrovascular Disease? A Clinical Practice Research Datalink Study 10.3899/jrheum.151024 Authors: J. Robson, A. Kiran, J. Maskell, A. Hutchings, N. Arden, B. Dasgupta, W. Hamilton, A. Emin, D. Culliford, R. Luqmani
2003	Who receives lipid-lowering drugs: the effects of comorbidities and patient characteristics on treatment initiation Authors: C. Yang, S. Jick, M. Testa
1998	Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database Authors: J. Bashford, J. Norwood, S. Chapman
2004	Why has antibiotic prescribing for respiratory illness declined in primary care? A longitudinal study using the General Practice Research Database 10.1093/pubmed/fdh160 Authors: M. Ashworth, R. Latinovic, J. Charlton, K. Cox, G. Rowlands, M. Gulliford
2014	Withdrawing performance indicators: retrospective analysis of general practice performance under UK Quality and Outcomes Framework 10.1136/bmj.g330 Authors: E. Kontopantelis, D. Springate, D. Reeves, D. Ashcroft, J. Valderas, T. Doran
2024	Within-episode repeat antibiotic prescriptions in patients with respiratory tract infections: A population-based cohort study 10.1016/j.jinf.2024.106135 Authors: A. Lalmohamed, R. Venekamp, A. Bolhuis, P. Souverein, Jhhm van de Wijgert, M. Gulliford, A. Hay
2021	Women with Polycystic Ovary Syndrome have an increased risk of major cardiovascular events: a population study 10.1210/clinem/dgab392 Authors: T. Berni, C. Morgan, D. Rees
2019	Workload impact of the Quality and Outcomes Framework for patients with diabetes: an interrupted time series in general practice 10.3399/bjgp19X704645 Authors: C. Gilbert, V. Allgar, T. Doran
2021	Younger people with rheumatoid arthritis are at increased risk of fracture even before age 50 years: a population-based cohort study 10.1007/s00198-021-05862-1 Authors: J. Erwin, D. Enki, A. Woolf
2018	Zoster vaccination inequalities: A population based cohort study using linked data from the UK Clinical Practice Research Datalink 10.1371/journal.pone.0207183 Authors: A. Jain, J. Walker, R. Mathur, H. Forbes, S. Langan, L. Smeeth, A. van Hoek, S. Thomas
2021	β-blocker prescription is associated with lower cumulative risk of knee osteoarthritis and knee pain consultations in primary care: a propensity score matched cohort study 10.1093/rheumatology/keab234 Authors: G. Nakafero, M. Grainge, A. Valdes, N. Townsend, C. Mallen, W. Zhang, M. Doherty, M. Mamas, A. Abhishek
2022	β-Blockers and the Risk of Depression: A Matched Case-Control Study 10.1007/s40264-021-01140-5 Authors: D. Bornand, D. Reinau, S. Jick, C. Meier